Advisors Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $170K | Sell |
|
|||||
2025
Q1 | $271K | Sell |
|
|||||
2024
Q4 | $278K | Sell |
|
|||||
2024
Q3 | $805K | Buy |
|
|||||
2024
Q2 | $928K | Buy |
|
|||||
2024
Q1 | $907K | Buy |
|
|||||
2023
Q4 | $881K | Sell |
|
|||||
2023
Q3 | $897K | Buy |
|
|||||
2023
Q2 | $825K | Buy |
|
|||||
2023
Q1 | $821K | Buy |
|
|||||
2022
Q4 | $753K | Buy |
|
|||||
2022
Q3 | $33K | Sell |
|
|||||
2022
Q2 | $80K | Sell |
|
|||||
2022
Q1 | $975K | Sell |
|
|||||
2021
Q4 | $1.18M | Sell |
|
|||||
2021
Q3 | $1.05M | Sell |
|
|||||
2021
Q2 | $1.64M | Sell |
|
|||||
2021
Q1 | $1.49M | Sell |
|
|||||
2020
Q4 | $1.87M | Buy |
|
|||||
2020
Q3 | $1.33M | Buy |
|
|||||
2020
Q2 | $1.17M | Buy |
|
|||||
2020
Q1 | $267K | Buy |
|
|||||
2019
Q4 | $262K | Sell |
|
|||||
2019
Q3 | $216K | Sell |
|
|||||
2019
Q2 | $293K | Sell |
|
|||||
2019
Q1 | $316K | Sell |
|
|||||
2018
Q4 | $623K | Sell |
|
|||||
2018
Q3 | $963K | Sell |
|
|||||
2018
Q2 | $1.01M | Sell |
|
|||||
2018
Q1 | $1.24M | Sell |
|
|||||
2017
Q4 | $1.4M | Sell |
|
|||||
2017
Q3 | $1.51M | Sell |
|
|||||
2017
Q2 | $2M | Sell |
|
|||||
2017
Q1 | $1.97M | Sell |
|
|||||
2016
Q4 | $2.41M | Sell |
|
|||||
2016
Q3 | $2.71M | Sell |
|
|||||
2016
Q2 | $3.05M | Sell |
|
|||||
2016
Q1 | $3.52M | Sell |
|
|||||
2015
Q4 | $5.59M | Sell |
|
|||||
2015
Q3 | $6.1M | Sell |
|
|||||
2015
Q2 | $9.49M | Buy |
|
|||||
2015
Q1 | $7.69M | Buy |
|
|||||
2014
Q4 | $5.07M | Sell |
|
|||||
2014
Q3 | $4.27M | Buy |
|
|||||
2014
Q2 | $3.62M | Buy |
|
|||||
2014
Q1 | $3.5M | Buy |
|
|||||
2013
Q4 | $3.13M | Buy |
|
|||||
2013
Q3 | $2.56M | Buy |
|
|||||
2013
Q2 | $1.43M | Buy |
|